⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

NEO

NeoGenomics, Inc.

Healthcare · Diagnostics & Research

16.59USD

+0.2000 (+1.22%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on NEO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 16.59
P/E—
Dvd Ind Yld0.0%
P/B2.75
P/S2.8
Curr EV/T12M EBITDA100.1
Mkt Cap (USD)2.2B
Curr EV (USD)2.4B
2)

Per Share Data

EPS T12M-0.40
DPS—
Bk Val Per Sh6.14
Rev/Sh5.86
Cash/Sh1.13
Curr Shares Out130.2M
FCF/Sh-0.06
3)

Cash Flow Analysis

P/CF98.0
Curr P/FCF-293.7
CF/NI-0.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales2.9%
Eff Interest Rate1.4%
4)

Growth Potential

Dil EPS 1Y Gr-35.7%
Cap 1Y Gr-18.4%
BPS 1Y Gr-8.3%
R&D To Sales5.0%
Retention Rate100.0%
Rev 1Y Gr10.1%
FCF 1Y Gr36.0%
Assets 1Y Gr-17.0%
5)

Profitability

EBITDA-0.0B
EBIT-0.1B
Operating Margin-8.9%
Pretax Margin-7.1%
Net Margin-6.8%
ROA-3.8%
ROE-6.3%
ROC-5.6%
Asset Turnover0.56
6)

Structure

Current Ratio3.60
Quick Ratio3.04
Debt/Assets27.7%
Debt/Com Eq47.6%
Net Debt/EBITDA-6.82
Tot Debt/Capital32.3%
Gross Margin43.9%
EBIT/Int Exp-26.5

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.